POSTOPERATIVE68GA-DOTATATE/PET-CT IMAGING IS PROGNOSTIC FOR PROGRESSION-FREE SURVIVAL IN MENINGIOMA WHO GRADE 1: A PROSPECTIVE SINGLE-CENTER STUDY

被引：0
|
作者：
Teske, N. [1 ]
Biczok, A. [1 ]
Quach, S. [1 ]
Dekorsy, F. J. [1 ]
Forbrig, R. [1 ]
Bodensohn, R. [1 ]
Niyazi, M. [1 ]
Tonn, J. [1 ]
Albert, N. L. [1 ]
Schichor, C. [1 ]
Ueberschaer, M. [1 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Sch Med, Munich, Germany
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
10.1093/neuonc/noad137.375
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P15.11.B
引用
收藏
页数：1
相关论文
共 37 条
  • [31] Durable MRD and Imaging-Negative Remission ≥ 5 Years Post-Therapy Predicts Long-Term Progression-Free Survival in Multiple Myeloma Patients - a Single-Center Observational Study
    Chen, Lucia Y.
    Thibaud, Santiago
    Chari, Ajai
    Richter, Joshua
    Cho, Hearn Jay
    Sanchez, Larysa J.
    Rodriguez, Cesar
    Rossi, Adriana C.
    Richard, Shambavi
    Parekh, Samir
    Jagannath, Sundar
    BLOOD, 2023, 142
  • [32] Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
    Sonni, Ida
    Felker, Ely R.
    Lenis, Andrew T.
    Sisk, Anthony E.
    Bahri, Shadfar
    Allen-Auerbach, Martin
    Armstrong, Wesley R.
    Suvannarerg, Voraparee
    Tubtawee, Teeravut
    Grogan, Tristan
    Elashoff, David
    Eiber, Matthias
    Raman, Steven S.
    Czernin, Johannes
    Reiter, Robert E.
    Calais, Jeremie
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (06) : 847 - 854
  • [33] Head-to-head comparison of 68Ga-PSMA-11 PET/CT and mpMRI in the detection, intra-prostatic localization, and local extension of primary prostate cancer: A single-center imaging study with histopathology gold-standard.
    Sonni, Ida
    Felker, Ely
    Lenis, Andrew Thomas
    Sisk, Anthony E.
    Bahri, Shadfar
    Auerbach, Martin S.
    Armstrong, Wesley R.
    Suvannarerg, Voraparee
    Tubtawee, Teeravut
    Grogan, Tristan
    Elashoff, David
    Czernin, Johannes
    Raman, Steven
    Reiter, Robert Evan
    Calais, Jeremie
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [34] Prognostic factors of overall and prostate-specific antigen-progression-free survival in metastatic castration-resistant prostate cancer patients treated with 177Lu-PSMA-617. A single-center prospective observational study
    Telli, Tugce
    Tuncel, Murat
    Karabulut, Erdem
    Aksoy, Sercan
    Erman, Mustafa
    Akdogan, Bulent
    Caglar, Meltem
    PROSTATE, 2023, 83 (08): : 792 - 800
  • [35] Stereotactic radiotherapy for 68Ga-PSMA and 18F-FDG PET/CT detected lesions in early non-metastatic castration-resistant prostate cancer (PSA≤2ng/ml): A prospective single-center study
    Pan, J.
    Ye, D.
    Zhu, Y.
    EUROPEAN UROLOGY, 2022, 81 : S315 - S315
  • [36] Comparison of Robotic-arm assisted 68Ga PSMA PET/CT guided prostate biopsy versus MR-directed TRUS guided prostate biopsy: A prospective randomized single-center study to assess diagnostic performance and participant safety.
    Kumar, Rajender
    Ram, Aravindh
    Mittal, Bhagwant
    Singh, Harmandeep
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [37] The prognostic role of 18F-FDG PET/CT in patients with locally advanced resectable esophageal squamous cell carcinoma(ESCC) submitted to neoadjuvant PD-L1 blockade therapy: A single-center prospective study
    Yang, R.
    He, Y.
    Zheng, Z.
    Lin, Y.
    Gao, H.
    Shi, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S135 - S135
1234